Mate, they have been saying for a while now that they are are well and truly focused only on Sofdra, so your refusal to believe may have to soften. I hope you're inkling is right, but to progress the other products they need to conduct trials. To conduct trials you need money, which usually involves telling the market. At best, maybe our management have planned a runway of trials and programs to move straight into when funding becomes available.
Bot Chart, page-11952
-
- There are more pages in this discussion • 3,030 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.0¢ | $1.949M | 5.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 163455 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 33207 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |